Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/diabetes-and-covid-19/descriptif_4871370
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=4871370

0 article 

 Frais de port 0,01€*

Exclusivité web : à partir de 35 euros d’achat, frais de port à 1 centime pour les expéditions vers la France métropolitaine, la Suisse et l’UE avec Colissimo ou GLS

Diabetes and COVID-19, 1st ed. 2023 Considerations and Clinical Management Contemporary Endocrinology Series

Langue : Anglais
Couverture de l’ouvrage Diabetes and COVID-19
Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology, infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine.

Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions. 

  1. ​COVID-19: epidemiology, etiology, clinical manifestations, diagnosis, therapeutic options, and prevention
  2. Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistance 
  3. Risk of COVID-19 in Persons with Diabetes
  4. Pathophysiology of Lung Dysfunction in Diabetes 
  5. Diabetic kidney disease and COVID-19
  6. The Impact of COVID-19 on Diabetic Foot Ulcers
  7. Co-morbid obesity and its impact on diabetes and COVID-19
  8. Overview of Inpatient Mgt of Diabetes and COVID 19
  9. Management of critically ill persons with COVID-19 and diabetes
  10. Managing Outpatient Diabetes in Persons with COVID-19 and Diabetes
  11. The Use of Diabetes Technology In Persons With Diabetes and Coronavirus 2019 (COVID-19)
  12. COVID-19 Vaccination in Persons with Diabetes 
  13. COVID-19 Vaccination in Persons with Diabetes
  14. Long-haul COVID Symptoms in Person with Diabetes

Alyson K. Myers, MD, Division of Endocrinology, Department of Medicine, Montefiore Einstein, Bronx, NY

Comprehensive review of diabetes and COVID-19

Discussion of both inpatient and outpatient management of diabetes and COVID-19

Authored by a diverse group of providers

Date de parution :

Ouvrage de 219 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

147,69 €

Ajouter au panier